| Literature DB >> 22691465 |
Nashwa Nabil Kamal1, Merhan Mamdouh Ragy.
Abstract
BACKGROUND: The prevalence and magnitude of obesity in the children and the adolescents have increased dramatically in the developing countries over the last 20-30 years. The prevalence of metabolic syndrome (MS) in children is increasing. AIM: This study aimed to investigate the changes of C-reactive protein (CRP), leptin, insulin, and blood lipids before and after the exercise therapy in normal and obese children (with or without metabolic syndrome).Entities:
Year: 2012 PMID: 22691465 PMCID: PMC3536685 DOI: 10.1186/1758-5996-4-27
Source DB: PubMed Journal: Diabetol Metab Syndr ISSN: 1758-5996 Impact factor: 3.320
Clinical and biological characteristics of the studied population according to sex
| 10.05 ± 1.16 | 10.5 ± 1.27 | Age (y) |
| 55.4 ± 7.8 | 57.6 ± 8.4 | Weight (kg) |
| 146.3 ± 8.7 | 149.4 ± 8.8 | Height (cm) |
| 21.4 ± 6.1 | 22.7 ± 6.4 | BMI (kg/m2) |
| 70.2 ± 9.5 | 70.4 ± 10.6 | Waist circumference |
| 0.84 ± 0.05 | 0.83 ± 0.06 | Waist-hip ratio |
| 112.3 ± 7.7 | 114.8 ± 8.9 | Systolic BP (mmHg) |
| 74.6 ± 8.04 | 73.9 ± 6.9 | diastolic BP (mmHg) |
| 160 ± 24.9 | 161.5 ± 21.6 | Total cholesterol (mg/dL)) |
| 98.4 ± 15.8 | 100.3 ± 13.9 | LDL ± C (mg/dL) |
| 45.8 ± 8.2 | 47.1 ± 8.6 | HDL-C (mg/dL) |
| 88 (75–135) | 95 (72–150) | Triglyceride (mg/dL) † |
| 85.9 ± 7.3 | 88.4 ± 10.9 | Glucose (mg/dL) |
| 15.3 ± 4.6 | 14.8 ± 4.9 | Insulin ( IU/mL) |
| 2.6 ± 0.8 | 2.7 ± 0.8 | HOMA-IR |
| 0.24 ( 0.01-2.5) | 0.9 ( 0.01-2.6) | CRP (mg/L) † |
| 5.7 (0.6-21.5) | 6.5 (0.6-36.5) | Serum leptin (ng/mL) † |
Data marked with † were presented as medians (interquartile ranges) and all others were presented as means ± standard deviations.
Metabolic profile and metabolic syndrome components among the studied children according to sex
| BMI > 85th percentile | 16 (100) | 28 (100) | 44 (100) | 0 (0) | 0 (0) | 0 (0) | - |
| Impairment of glucose tolerance | 3 (18.7) | 4 (14.3) | 7 (15.9) | 2 (8.3) | 1 (4) | 3 (6.1) | 0.9 (0.86-1.04) |
| Systolic blood Pressure > 95th Percentile | 5 (31.2) | 7 (25) | 12 (27.3) | 2 (8.3) | 3 (12) | 5 (10.2) | 0.8 (0.7-0.9) b |
| HDL < 5th percentile | 6 (37.5) | 9 (32.1) | 15 (34.1) | 2 (8.2) | 0 (0) | 2 (4.1) | 1.2 (1.02-1.3) d |
| Triglycerides > 95th percentile | 3 (18.7) | 8 (28.6) | 11 (25) | 1 (4.2) | 3 (12) | 4 (8.2) | 0.9 (0.8-0.9) c |
| Metabolic syndrome | 4 (25) | 8 (28.6) | 12 (27.3) | 0 (0) | 0 (0) | (0) | - |
b significant at p < 0.05; c significant at p < 0.01; d significant at p < 0.001.
a OR calculated from logistic regression test by using enter method.
Clinical and biological characteristics of the studied population with weight and metabolic syndrome status specification
| Age (y) | 10.1 ± 1.21 | 10.2 ± 1.2 | 11.04 ± 1.15a, b |
| Weight (kg) | 62.6 ± 4.1 C | 50.2 ± 3.7 | 67.1 ± 6.3 a, b |
| Height (cm) | 146.5 ± 10.3 | 147.6 ± 7.5 | 153.9 ± 8.5 a, b |
| BMI (kg/m2) | 27.01 ± 3.9 C | 17.2 ± 2.5 | 29.4 ± 4.8 a, b |
| Waist circumference | 77.3 ± 5.2 C | 62.7 ± 6.6 | 83.25 ± 2.8 a, b |
| Waist-hip ratio | 0.85 ± 0.06 | 0.83 ± 0.06 | 0.88 ± 0.05 b |
| Systolic BP (mmHg) | 117.5 ± 6.8 C | 109.4 ± 6.9 | 121.7 ± 7.8 b |
| diastolic BP (mmHg) | 75.5 ± 8.3 C | 71.8 ± 6.3 | 80.4 ± 4.5 a b |
| Total cholesterol (mg/dL)) | 178.5 ± 16.8 C | 145.2 ± 13.6 | 177.7 ± 21.9 b |
| LDL ± C (mg/dL) | 107 ± 10.2 C | 92.6 ± 14.5 | 107.5 ± 12.1 b |
| HDL-C (mg/dL) | 45.8 ± 5.9 C | 50.5 ± 6.5 | 32 ±2.7 a, b |
| Triglyceride (mg/dL) | 95.5 (76–135) C | 85 (72–123) | 118.5 (110–150) a, b |
| Glucose (mg/dL) | 84.9 ± 5.7 | 84.1 ± 5.2 | 105.5 ± 11.04 a, b |
| Insulin ( IU/mL) | 14.4 ± 3.9 | 14.4 ± 4.9 | 19.3 ± 4.4 a, b |
| HOMA-IR | 2.7 ± 0.9 | 2.4 ± 0.6 | 3.3 ± 0.88 a, b |
| CRP (mg/L) | 1.25 ( 0.01-2.6) C | 0.2 ( 0.01-1.5) | 2.1 (1.2-3.1) a, b |
| Serum leptin (ng/mL) | 9.4 (0.6-36.5) C | 4.5 (0.6-12.4) | 15.2 (8.3-21.8) a, b |
a = significant difference between obese children with and without metabolic syndrome.
b = significant difference between non obese children and obese children with metabolic syndrome.
c = significant difference between non obese children and obese children without metabolic syndrome.
Pearson Correlation Coefficients between HOMA-IR and the individual components of the metabolic syndrome
| Triglycerides* | 0.41 | 0.001 |
| HDL-C | −0.20 | 0.05 |
| Systolic blood pressure | 0.28 | 0.005 |
| BMI > 85th percentile | 0.22 | 0.03 |
| Fasting glucose | 0.29 | 0.004 |
HDL-C = high-density lipoprotein cholesterol; HOMA-IR = insulin resistance as assessed by homeostasis model. *Spearman rho correlation.
Changes in clinical and biological characteristics among the studied groups undergoing 12 week exercise program
| | ||||||
|---|---|---|---|---|---|---|
| Weight (kg) | 50.2 ± 3.7 | 49.6 ± 3.7 | 62.6 ± 4.1 | 60.2 ± 4.3* | 67.1 ± 6.3 | 60.9 ± 2.8* |
| BMI (kg/m2) | 17.2 ± 2.5 | 16.8 ± 2.8 | 27.01 ± 3.9 | 24.8 ± 3.1* | 29.4 ± 4.8 | 24.2 ± 2.2* |
| Waist circumference | 62.7 ± 6.6 | 61.6 ± 5.9 | 77.3 ± 5.2 | 76.2 ± 5.6 | 83.25 ± 2.8 | 77.6 ± 5.2* |
| Waist-hip ratio | 0.83 ± 0.06 | 0.80 ± 0.08 | 0.85 ± 0.06 | 0.83 ± 0.06 | 0.88 ± 0.05 | 0.85 ± 0.06 |
| Systolic BP (mmHg) | 109.4 ± 6.9 | 109.7 ± 7.1 | 117.5 ± 6.8 | 116.4 ± 7.2 | 121.7 ± 7.8 | 117.5 ± 6.9 |
| diastolic BP (mmHg) | 71.8 ± 6.3 | 71.6 ± 5.8 | 75.5 ± 8.3 | 72.2 ± 8.2 | 80.4 ± 4.5 | 77.1 ± 8.9 |
| Total cholesterol (mg/dL)) | 145.2 ± 13.6 | 139.3 ± 15.1 | 178.5 ± 16.8 | 154.8 ± 20.7* | 177.7 ± 21.9 | 166.3 ± 9.9 |
| LDL ± C (mg/dL) | 92.6 ± 14.5 | 91.7 ± 14.9 | 107 ± 10.2 | 99.4 ± 15.4* | 107.5 ± 12.1 | 103.8 ± 15.7 |
| HDL-C (mg/dL) | 50.5 ± 6.5 | 51.9 ±5.4 | 45.8 ± 5.9 | 49.3 ±6.5* | 32 ±2.7 | 43.4 ±6.2* |
| Triglyceride (mg/dL) | 85 (72–123) | 85 (72–112) | 95.5 (76–135) | 95.4 (76–124) | 118.5 (110–150) | 103.5 (89–135)* |
| Glucose (mg/dL) | 84.1 ± 5.2 | 83.3 ± 5.6 | 84.9 ± 5.7 | 84.6 ± 5.5 | 105.5 ± 11.04 | 91.7 ± 10.8* |
| Insulin ( IU/mL) | 14.4 ± 4.9 | 13.9 ± 4.9 | 14.4 ± 3.9 | 14.2 ± 4.6 | 19.3 ± 4.4 | 13.6 ± 4.01* |
| HOMA-IR | 2.4 ± 0.6 | 2.4 ± 0.5 | 2.7 ± 0.9 | 2.5 ± 0.7 | 3.3 ± 0.88 | 2.7 ± 0.9 |
| CRP (mg/L) | 0.2( 0.01-1.5) | 0.2 (0.01-1.5) | 1.25( 0.01-2.6) | 0.22(0.01-2.1)* | 2.1 (1.2-3.1) | 1.2 (0.04-2.25)* |
| Serum leptin (ng/mL) | 4.5 (0.6-12.4) | 3.8 (0.6-7.5) | 9.4 (0.6-36.5) | 5.7(0.6-16.9)* | 15.2 (8.3-21.8) | 6.1 (0.6-21.5) |
*P < 0.05 for baseline vs after 12 weeks of physical exercise program within each group.
Figure 1Variables in metabolic syndrome components before and after exercise intervention in all exercisers (n = 93).